Subscribe To
CNTG / Centogene N.V. (CNTG) CEO Kim Stratton on Q4 2021 Results - Earnings Call Transcript
CNTG News
By Market Watch
September 1, 2023
Centogene shares climb after study confirms biomarker for Gaucher disease
Shares of Centogene NV CNTG, +8.31% gained 7% premarket on Friday after the company announced data confirming the utility of its proprietary biomarker more_horizontal
By GlobeNewsWire
May 5, 2023
CENTOGENE to Participate in Upcoming Conferences in May
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 05, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner f more_horizontal
By GlobeNewsWire
December 1, 2022
CENTOGENE to Participate in Upcoming Conferences in December
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner more_horizontal
By GlobeNewsWire
November 10, 2022
CENTOGENE to Participate in Upcoming Conferences in November
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner more_horizontal
By Seeking Alpha
March 30, 2022
Centogene N.V. (CNTG) CEO Kim Stratton on Q4 2021 Results - Earnings Call Transcript
Centogene N.V. (CNTG) CEO Kim Stratton on Q4 2021 Results - Earnings Call Transcript more_horizontal
By Benzinga
October 6, 2021
Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases
Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for more_horizontal
By Benzinga
October 6, 2021
Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases
Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for more_horizontal
By Benzinga
October 6, 2021
Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases
Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for more_horizontal